Sandoz, a generic drug company, has launched three new generic drugs, clopidogrel, tacrolimus and pitavastatin, in Japan. Clopidogrel, a generic version of Sanofi's Plavix, is used for suppression of recurrence of ischemic cerebrovascular disorder. Individual.com, 1 week ago
Friday Feedback: The True Cost of Generic Drugs - MedPage Today, 3 weeks ago
Original article: Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in SwitzerlandBritish Journal of the Heart, 1 month ago Clinical profile of ACS patients treated with prasugrel, clopidogrel varies in US Orthopedics Today, 1 month ago Patient Profiles Differ With Prasugrel vs. Clopidogrel for PCI Monthly Prescribing Reference, 1 month ago
You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 26 days for your content allowance to be renewed. Sign up for a free trial to ...FirstWord Pharma, 1 month ago Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients Diagnostic & Invasive Cardiology, 1 month ago Ticagrelor More Effective Than Clopidogrel in Low-Risk Patients Undergoing PCI: Presented at SCAI FirstWord Pharma, 1 month ago SCAI Release: Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel For Ad Hoc PCI Patients 5/7/2015 ClinicSpace, 1 month ago
Compared to Clopidogrel, Prasugrel Did Not Have a Higher Risk of Bleeding at 90 Days 12:05 ET from SCAI SAN DIEGO, May 8, 2015 /PRNewswire/ -- Prasugrel (Effient®) is more likely to be given to lower-risk heart disease patients undergoing ...PR Newswire, 1 month ago Prasugrel More Likely Candidate for Low-Risk Heart Disease Patients Diagnostic & Invasive Cardiology, 1 month ago
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel vs. clopidogrel and managed without revascularization: Insights from the TRILOGY ACS Trial
Concomitant use of proton-pump inhibitors (PPIs) has been implicated in diminished antiplatelet response to clopidogrel and an increased risk of ischemic events, but primarily among patients undergoing percutaneous coronary intervention. We sought ...American Heart Journal, 3 weeks ago Proton Pump Inhibitor Use Associated With Increased Risk of Myocardial Infarction MedIndia, 1 day ago PPIs up the risk of myocardial infarction 6minutes.net.au, 1 week ago Gastric reflux drugs and heart attacks Deccan Herald, 1 week ago
NEW YORK (Reuters Health) -- Three months of dual treatment with clopidogrel and aspirin after acute minor stroke or high-risk transient ischemic attack (TIA) had lasting benefit over 1 year in the CHANCE trial. The results of 1-year follow-up ...MedPage Today, 1 month ago Dual antiplatelet therapy with clopidogrel and aspirin reduces stroke risk Cardiovascular Business, 1 month ago Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE): 1-Year Outcomes [Original Articles] Circulation: Cardiovascular Interventions, 1 month ago Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis European Heart Journal, 2 days ago
New Heart Disease Findings Reported from University of Lausanne Hospital (Safety profile of prasugrel and clopidogrel in patients with acute coronary...
New Heart Disease Findings Reported from University of Lausanne Hospital (Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland) By a News Reporter-Staff News Editor at Heart Disease Weekly Current ...Pharmacy Choice, 4 weeks ago Findings in Heart Disease Reported from University Hospital (Republished: Antiplatelet therapy for secondary prevention of coronary artery disease) Pharmacy Choice, 2 weeks ago New Angiology Study Findings Have Been Reported from St. Antonius Hospital (The role of perioperative antiplatelet therapy and platelet reactivity... Pharmacy Choice, 1 month ago
Jeannette Y. Wick, RPh, MBA, FASCP Patients with heart failure (HF) often receive clopidogrel and angiotensin-converting enzyme (ACE) inhibitors concurrently. Because clopidogrel inhibits the enzyme carboxylesterase 1 (CES1), and CES1 converts ...Pharmacy Times, 1 month ago Some Heartburn Drugs May Boost Risk of Heart Attack Bioscience Technology Online, 2 weeks ago Popular antacids linked to higher heart risks Consumer Affairs, 3 weeks ago Some Heartburn Drugs Could Up Heart Attack Risk AARP Bulletin Today, 3 weeks ago
My notice: Add / edit notice my watchlist Cancel Save notice Share on On my watchlist Important information You are currently not logged in to my.bionity.com . Your changes will in fact be stored however can be lost at all times. ...Bionity.com, 3 weeks ago
Defining the Link Between Chronic Kidney Disease, High Platelet Reactivity, and Clinical Outcomes in Clopidogrel-Treated Patients Undergoing Percutaneous Coronary Intervention [Editorials]
Francesco Franchi , MD, Fabiana Rollini , MD and Dominick J. Angiolillo , MD, PhD From the University of Florida College of Medicine, Jacksonville. Correspondence to Dominick J. Angiolillo, MD, PhD, Division of Cardiology, University of ...Circulation: Cardiovascular Interventions, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!